Anavex Life Sciences Corp

10. Sept. 2026, 20:07 UTC

Anavex Life Sciences shares are lower as PVG Asset Management plans a proxy campaign to change the board, citing concerns over governance and leadership.

9. Sept. 2026, 19:46 UTC

Anavex Life Sciences shares decline as PVG Asset Management calls for a board replacement, citing concerns over inexperience and funding issues for upcoming trials.

8. Sept. 2026, 20:21 UTC

Anavex Life Sciences Corp shares are lower in after-market trading, declining significantly below the 20-day moving average and near the lower end of its one-month range.

4. Sept. 2026, 19:46 UTC

Anavex Life Sciences is rising as PVG Asset Management proposes changes to its Board of Directors, aiming to enhance governance and accountability.

3. Sept. 2026, 19:46 UTC

Anavex Life Sciences has regained Nasdaq compliance but shares are lower. The stock remains below its 20-day moving average amid broader market sentiment.

2. Sept. 2026, 21:01 UTC

Anavex Life Sciences regained compliance with Nasdaq rules after filing overdue reports. Shares are lower in after-market trading, reflecting broader market dynamics.

1. Sept. 2026, 19:54 UTC

Anavex Life Sciences Corp shares are trading higher today, recovering from an early dip amid broader market pressures and rising Treasury yields.

31. Aug. 2026, 21:01 UTC

Anavex Life Sciences Corp is trading higher in after-market hours, rebounding from earlier lows after five sessions of declines.

28. Aug. 2026, 19:16 UTC

Anavex Life Sciences Corp. shares are lower today, extending a three-session decline amid broader market concerns over inflation and corporate growth expectations.

27. Aug. 2026, 22:01 UTC

Anavex Life Sciences Corp is rising in after-hours trading, continuing a gradual ascent since Thursday's close, despite broader market conditions and no specific news.

26. Aug. 2026, 23:41 UTC

Anavex Life Sciences Corp shares are higher during after-market hours, supported by a broader market trend. No specific company news was identified.

25. Aug. 2026, 20:07 UTC

Anavex Life Sciences reported Q3 2026 net income of $7.8 million, returning to profitability. Shares are trading higher following the financial results and pipeline updates.

24. Aug. 2026, 23:11 UTC

Anavex Life Sciences Corp shares are higher in after-market trading, building on positive momentum from Monday's close and a strong one-month performance.

21. Aug. 2026, 20:06 UTC

Anavex Life Sciences Corp is gaining amid broader market strength, reflecting a robust performance in biotechnology and positive investor sentiment despite no specific company news.

20. Aug. 2026, 20:01 UTC

Anavex Life Sciences Corp shares are lower today, driven by significant weakness in the Biotechnology sub-sector and broader trends affecting the sector.

19. Aug. 2026, 19:44 UTC

Anavex Life Sciences Corp is trading sharply higher, reaching a session high and maintaining a position above its 20-day moving average. No specific news was identified.

17. Aug. 2026, 19:46 UTC

Anavex Life Sciences has communicated with stockholders about director nominees amid a "Hold" rating from analysts. Shares are trading roughly flat since Friday's close.

14. Aug. 2026, 20:13 UTC

Anavex Life Sciences shares are lower in after-market hours, influenced by disappointing U.S. retail sales data and declining consumer sentiment.

13. Aug. 2026, 22:51 UTC

Anavex Life Sciences Corp shares are lower in after-market hours, continuing a trend of declines over three consecutive sessions. No specific news was identified.

12. Aug. 2026, 19:46 UTC

Anavex Life Sciences Corp shares are lower today, continuing a decline since Tuesday's close, despite remaining above the 20-day moving average.

11. Aug. 2026, 23:22 UTC

Anavex Life Sciences Corp is trading lower in after-market hours with no specific news. The stock remains well above its 20-day moving average.

10. Aug. 2026, 19:46 UTC

Anavex Life Sciences is trading higher today, despite no specific news. Broader market sentiment is influenced by upcoming inflation data and Fed policy expectations.

7. Aug. 2026, 22:16 UTC

Anavex Life Sciences Corp is higher in after-market trading, continuing a trend of gains over the last seven sessions, despite no specific news identified.

6. Aug. 2026, 23:51 UTC

Anavex Life Sciences Corp is rising in after-market trading, reaching a high shortly after the market closed, despite no specific news driving the increase.

5. Aug. 2026, 21:01 UTC

Anavex Life Sciences shares fell in after-market trading, declining significantly despite being above its 20-day moving average and near the top of its one-month range.

4. Aug. 2026, 19:51 UTC

Anavex Life Sciences Corp is rising amid broader market strength and a decline in crude oil prices, despite pulling back from earlier session highs.

3. Aug. 2026, 20:02 UTC

Anavex Life Sciences Corp announces board changes amid a proxy fight, urging stockholders to reject PVG Asset Management's attempt to replace the board. Shares are higher.

30. Juli 2026, 19:39 UTC

Anavex Life Sciences reported Q2 earnings of -$0.06 per share, beating expectations. Shares remain higher since Wednesday's close despite pulling back from session highs.

29. Juli 2026, 22:31 UTC

Anavex Life Sciences Corp shares are higher in after-market trading, reflecting broader market gains following the Federal Reserve's decision to maintain interest rates.

28. Juli 2026, 21:01 UTC

Anavex Life Sciences Corp shares are lower in after-market hours, currently 1.45% below their 20-day moving average. No specific news was identified.